MEDS Revenue and Competitors
Estimated Revenue & Valuation
- MEDS's estimated annual revenue is currently $17.5M per year.
- MEDS's estimated revenue per employee is $140,000
Employee Data
- MEDS has 125 Employees.
- MEDS grew their employee count by -5% last year.
MEDS's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Co-founder and CTO at MEDS | Reveal Email/Phone |
3 | Head Performance | Reveal Email/Phone |
4 | Head Technology | Reveal Email/Phone |
5 | Category Manager | Reveal Email/Phone |
6 | Lagermedarbetare | Reveal Email/Phone |
7 | Warehouse Worker | Reveal Email/Phone |
8 | Group financial controller | Reveal Email/Phone |
9 | System developer | Reveal Email/Phone |
10 | Developer | Reveal Email/Phone |
MEDS Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.3M | 10 | -17% | N/A | N/A |
What Is MEDS?
MEDS delivers within hours from order straight to the door in Stockholm and same day in many parts of Sweden
keywords:N/AN/A
Total Funding
125
Number of Employees
$17.5M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MEDS News
2022-04-19 - US meds spending spiked last year, but will fall quickly -
Overall spending on medicines rose 12% in 2021 to $407 billion, driven by a $29 billion spend on COVID-19 vaccines and medicines. Without that...
2022-04-17 - April 2022: Kaplan MCAT stumpers put pre-meds to the test
For students preparing for medical school, the AMA pre-med glossary guide has the answers to frequently asked questions.
2022-04-17 - Fetal exposure to meds may affect infants' brain development
Fetal exposure to meds may affect infants' brain development. Date: April 20, 2022; Source: University of Helsinki; Summary: A new study demonstrates that...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18.1M | 125 | 5% | N/A |
#2 | $25.6M | 125 | 37% | N/A |
#3 | $18.8M | 125 | 25% | N/A |
#4 | $7.5M | 125 | -4% | N/A |
#5 | $26.3M | 125 | 32% | N/A |